But they’ve mostly accused Price, a wealthy former orthopedic surgeon, of conflicts of interest by acquiring stocks in health care companies and pushing legislation that could help those firms.
They’ve especially targeted his acquisition of shares in Innate Immunotherapeutics, an Australian biotech firm that’s said Price got a special insider’s deal. Price, who has said he learned of the opportunity from a fellow lawmaker, Rep. Chris Collins, R-N.Y., had testified to Congress that the shares were available to all investors.
“If I were a prosecutor, I’d say this case has real potential,” Senate Minority Leader Chuck Schumer, D-N.Y., Wednesday.
This week has featured overnight Senate sessions as GOP leaders are grinding through a thicket of controversial picks.
Epitomizing the sharp-edged partisanship surrounding confirmation of Trump’s Cabinet nominees, Sen. Elizabeth Warren was given a rare rebuke Tuesday evening for quoting Coretta Scott King, widow of the late civil rights leader Martin Luther King Jr., on the Senate floor. King wrote that as an acting federal prosecutor in Alabama, Sessions used his power to “chill the free exercise of the vote by black citizens.”
